KRM Ayurveda — 360° view

KRM Ayurveda, a company in the Pharmaceuticals industry, reported revenue of ₹35 crore and net profit of ₹8.23 crore for the September 2026 quarter.

KRM Ayurveda (NSE: KRMAYURVED-SM) closed at ₹220.35 on 20 Nov 2026. Its market capitalisation is ₹468 crore and it trades at 16.0 times earnings.

Share price
₹220.35 (20 Nov 2026)
Market cap
₹468 Cr (20 Nov 2026)
P/E
16.04 (20 Nov 2026)
Revenue
₹35 Cr (September 2026 quarter)
Net profit
₹8 Cr (September 2026 quarter)
ROCE
35.3% (FY26)
ROE
29.0% (FY26)
Book value
₹62.1 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹326.85 / ₹215.05 (20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: KRMAYURVED-SM

Incorporated on 3 September 2019, KRM Ayurveda Ltd. is operating a network of hospitals and clinics across multiple cities in India.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.